TITLE:
Director of Investor Relations
COMPANY:
Fortress Biotech, Inc. (“Fortress” or the “Company”) is an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic products and product candidates. Fortress is a commercial stage life sciences company with a robust development stage pipeline and a uniquely scalable and risk-averse business model. It is the parent company to four public partner companies and seven additional private subsidiaries, all focused on drug development and commercialization. Fortress has equity ownership in the partner companies ranging from ~18% to 82%, potential royalty streams of 4.5% from most partner companies and annual equity dividends of 2.5% from most companies. The Company reported record net revenue in the first half of 2022 of $42.8 million, an increase of 45.5% versus the first half of 2021. In 2021, the total R&D spend on Fortress’ programs exceeded $150 million. However, the R&D spend at Fortress was only ~$6 million, with the balance being covered by partner companies Fortress controls as well as partners of partner companies. Additionally, in most instances through equity, royalties and milestones, Fortress anticipates 20-40% of the total economics/value of these programs within several quarters to a few years after product launch.
Fortress has in-licensed and/or acquired 60 products and product candidates since 2014 and it has more than 20 full and part time search and evaluate team members continuously scouring the globe for drug development candidates and already marketed biopharma products. Fortress currently has eight marketed pharmaceutical products and 31 development stage programs including 20 clinical-stage programs in 31 clinical trials, of which four programs are in seven pivotal clinical trials. One Biologics Licensing Application filing is expected by January 2023 for a monoclonal antibody in oncology. Fortress aims to become a positive cash flow earnings company quickly through a diversified development and commercialization portfolio without taking single product risk. The Company focuses on scaling existing partner companies and the creation of new subsidiaries through efficient and targeted business development. Our R&D pipeline comes from the over 14,000 unique clinical stage drug candidates all over the world supported by over $350 billion in spending. We find many of these opportunities are unknown enough to be very inefficiently priced.
A recent example of the business model is when Fortress found and acquired CAEL-101 from a major U.S. medical research center, and on a $200,000 investment, the Company sold CAEL-101 to AstraZeneca in the fourth quarter of 2021 for $150 million upfront and an additional $350 million in potential regulatory and commercial milestones in coming years. Fortress receives ~42% of total proceeds.
We are looking for a motivated, resourceful and experienced life sciences investor relations professional who will be excited by and excel at communicating our uniquely scalable business model to both life science investors and non-life science equity investors – particularly those that would value a very broad and deeply diversified portfolio of development stage and marketed products. The Director of Investor Relations is a core part of the Fortress team and will also work collaboratively with our 11 controlled companies and their teams. The position requires knowledge of life sciences investor relations.
POSITION:
The position will be located in our Miami, FL office, and reports to the Chairman & CEO.
JOB DESCRIPTION |
The Director of Investor Relations is responsible for organizing roadshows and communicating the organization’s position to/developing relations with appropriate institutional investors, brokers and media. Duties and Responsibilities: The essential functions of the role are below, but not limited to:
Competencies: To perform the job successfully, an individual should demonstrate the following competencies to perform the essential functions of this position.
|
Position Type/Expected Hours of Work
This is a full-time position in our Miami, FL office.
Travel
Travel will be required up to 20% of the time.
Required Education and Experience
Bachelor’s degree or equivalent experience is required.
At least five years of previous experience in a related biotech or pharma investor relations role is preferred.
Must be able to work independently and complete projects with limited supervision, as well as to work as a member of a team.
Excellent interpersonal, verbal and written communication skills are required.
Compensation:
Compensation is commensurate with experience to include base salary, bonus potential, equity, and an attractive benefits package.
Fortress Biotech, Inc. is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, sexual orientation, gender identity, disability status, protected veteran status, or any other characteristic protected by applicable law.
Director of Investor RelationsMiami, FL: Apply Now